Darunavir Cobicistat Emtricitabine And Tenofovir Alafenamide + P Gp Or Bcrp Substrates Interaction
Moderateinteraction on record
Description
Co-administration may result in increased plasma concentrations of P-gp substrates due to transporter inhibition.
Mechanism
Cobicistat inhibits P-glycoprotein transporter
Source: NLP:darunavir, cobicistat, emtricitabine, and tenofovir alafenamide